Arsenic trioxide: Its role in acute promyelocytic leukemia and potential in other hematologic malignancies

Medicine and Dentistry

• Chemotherapy 100%
• In Vitro 100%
• Hematologic Malignancy 100%
• Arsenic Trioxide 100%
• Patient 100%
• Therapeutic Procedure 100%
• Diseases 50%
• Acute Promyelocytic Leukemia 50%
• Combination Therapy 50%
• Anthracycline 50%
• Recurrence Risk 50%
• Anticarcinogen 50%
• Glutathione 50%
• Chemotherapeutic Agent 50%
• Reducing Agent 50%
• Mechanism of Action 50%
• Clinical Support 50%

INIS

• patients 100%
• in vitro 100%
• malignancies 100%
• arsenic 100%
• data 50%
• range 50%
• therapy 50%
• diseases 50%
• investigations 50%
• leukemia 50%
• chemotherapy 50%
• glutathione 50%
• reducing agents 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Hematologic Malignancy 100%
• Arsenite 100%
• Diseases 50%
• Anthracycline 50%
• Combination Therapy 50%
• Anticarcinogen 50%
• Promyelocytic Leukemia 50%
• Glutathione 50%
• Reducing Agent 50%
• Recurrence Risk 50%